Michael, Delayed Diagnosis
More Patient Stories

Michael

Name: Michael
Age: 47
Age at type 1 Gaucher diagnosis: 43
Ethnicity: African American
Treatment history:
VPRIV, 4 years
Symptoms at baseline:
Moderately enlarged spleen and liver, severe thrombocytopenia, low hemoglobin, reduced bone mineral density3
Last check-up:
Maintained improvements in spleen volume, hemoglobin count, and platelet count1,4,5

*Not an actual patient. This is a hypothetical patient profile.

*Not an actual patient. This is a hypothetical patient profile.

Michael, Delayed Diagnosis
Name: Michael
Age: 47
Age at type 1 Gaucher diagnosis: 43
Ethnicity: African American
Treatment history: VPRIV, 4 years
Symptoms at baseline:
Moderately enlarged spleen and liver, severe thrombocytopenia, low hemoglobin, reduced bone mineral density3
Last check-up:
Maintained improvements in spleen volume, hemoglobin count, and platelet count1,4,5

Michael had experienced persistent fatigue and easy bruising4 for many years before receiving an incorrect diagnosis of immune thrombocytopenic purpura (ITP) in his 30s.5

His symptoms had progressed by the time he was correctly diagnosed, at the age of 43, with type 1 Gaucher disease.6

The geneticist who diagnosed Michael recommended starting treatment immediately. Michael and his doctor discussed treatment options and selected VPRIV. Once Michael had been prescribed VPRIV, he was able to utilize the QuickStart program to receive his first infusion while his prior authorization was being reviewed.

Consider
  • If patients are eligible, the QuickStart program allows for up to two free infusions while the patient’s prior authorization is still being reviewed.

Looking to start your patients on VPRIV? Start the process by downloading a OnePath® Start Form and filling it in with your patients to begin. Please contact OnePath® at 1-866-888-0660 with any questions.

VPRIV OnePath® Start Form

Download the full VPRIV Patient Profiles here.

VPRIV Patient Profiles